国家知识产权局信息显示，太原重工股份有限公司申请一项名为"纯电动汽车起重机智能监控系统"的专 利，公开号CN121317535A，申请日期为2025年11月。 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 财经频道更多独家策划、专家专栏，免费查阅>> 专利摘要显示，本发明属于起重机技术领域，公开了一种纯电动汽车起重机智能监控系统，该系统包 括：动力装置、控制模块、全景影像装置、轮胎监测装置、显示器和智能远程终端，动力装置用于对纯 电动汽车起重机提供能源动力，控制模块与动力装置连接，全景影像装置与控制模块连接，用于对控制 模块提供辅助控制信息，轮胎监测装置与控制模块连接，用于监测轮胎使用状态，预测使用寿命，显示 器与全景影像装置和轮胎监测装置连接，智能远程终端与控制模块、全景影像装置和轮胎监测装置连 接，用于远程获取纯电动汽车起重机操作信息及现场画面。本发明有效提高了行驶及作业安全，可实时 监控司机工作状态及起重机工作环境并进行实时通讯，有效提高了协同工作效率。 天眼查资料显示，太原重工股份有限公司，成立于1998年，位于太原市，是一家以从事专用设备制造业 为主的企 ...

Core Viewpoint - Jing Shan Light Machine will be classified as ST due to inflated profits exceeding 46 million yuan, highlighting regulatory zero tolerance for financial fraud [1][5][9]. Group 1: Financial Misconduct - Jing Shan Light Machine reported inflated revenue of 58.19 million yuan and inflated costs of 9.60 million yuan in 2018, resulting in an inflated profit of 46.70 million yuan, which accounted for 25.49% of the total profit disclosed for that year [7]. - The company and related responsible persons received an administrative penalty notice from the Hubei Securities Regulatory Bureau, indicating that the 2018 annual report contained false records [5][7]. Group 2: Regulatory Actions - Starting January 20, the company's stock will be suspended for one day and will be subject to other risk warnings, with the stock name changing to "ST Jing Ji" [8][9]. - The Hubei Securities Regulatory Bureau plans to impose a fine of 5 million yuan on the company and issue warnings and fines to responsible individuals, including 2.5 million yuan each for Li Jian, Luo Yuexiong, and Wang Jianping, and 300,000 yuan for Zeng Tao [7]. Group 3: Company Response - The board of Jing Shan Light Machine has apologized to investors and committed to enhancing internal control management systems and supervision mechanisms to prevent future issues [9].

Summary of Key Points Core Viewpoint - The company is providing guarantees for buyer credit business to support customers with good credit who require financing, thereby facilitating business development and improving cash flow efficiency [2][9][10]. Group 1: Overview of Buyer Credit Guarantee - The company accepts buyer credit as a payment method during sales to assist customers with financing needs [2]. - The total guarantee amount for buyer credit is capped at RMB 50 million, with individual credit terms not exceeding five years [2]. - The chairman is authorized to decide on the specific guarantees within the approved limit for a period of twelve months [2]. Group 2: Criteria for Guaranteed Clients - The company has established positive and negative screening criteria for selecting clients for buyer credit guarantees [3][6]. - Positive criteria include being a legally registered company in China, having good commercial credit, and no unresolved legal disputes [3][5]. - Negative criteria include significant external guarantee risks, previous defaults, and financial instability [6][7][8]. Group 3: Main Content of Guarantee Agreements - The company has not yet signed specific guarantee agreements with banks or financial institutions but will do so within the approved guarantee limits [8]. Group 4: Board and Audit Committee Opinions - The board and audit committee agree that the buyer credit business will alleviate short-term financial pressure for clients and enhance cash flow efficiency [9][10]. - They confirm that the decision-making process complies with legal regulations and will not adversely affect the company's operations [9][10]. Group 5: Current Guarantee Status - As of December 31, 2025, the company's total guarantees for buyer credit amounted to approximately RMB 47.94 million, representing 3.36% of the company's audited net assets as of December 31, 2024 [11].

（文章来源：证券日报） 证券日报网讯 1月16日，信宇人在互动平台回答投资者提问时表示，公司对欧盟市场的销售主要通过在 欧盟国家设立的子公司开展相关业务，该业务收入占公司整体收入的比例较小。 ...

证券日报网讯 1月16日，赛腾股份在互动平台回答投资者提问时表示，公司订单获取渠道并非仅为公开 招投标，还包含客户竞价采购、谈判采购等合规合作形式，该类订单无需履行公开招投标流程，相关信 息未在招投标公示渠道体现，故公开中标信息无法全面反映公司整体订单情况。 （编辑 丛可心） ...

Core Viewpoint - Hunan Wuxin Tunnel Intelligent Equipment Co., Ltd. has received approval for the acquisition of 100% equity of Wuxin Heavy Industry and 99.9057% equity of Xingzhong Technology, enhancing its competitive edge in the energy infrastructure, mining, port, and overseas markets [1] Group 1 - As of January 16, 2026, Wuxin's stock closed at 49.89 yuan, up 2.13% from the previous trading day, with a total market capitalization of 4.491 billion yuan [1] - The stock opened at 48.73 yuan, reached a high of 50.89 yuan, and a low of 48.73 yuan, with a trading volume of 1.87 billion yuan and a turnover rate of 4.29% [1] Group 2 - The company held an online investor relations event on January 15, 2026, to announce the completion of the asset transfer on December 25, 2025 [1] - Xingzhong Technology reported revenue of 1.029 billion yuan and a net profit of 191 million yuan for the first nine months of 2025, while Wuxin Heavy Industry reported revenue of 325 million yuan and a net profit of 63 million yuan during the same period [1] - The company is advancing the share issuance registration process and plans to enhance overall competitiveness through synergies in procurement, sales, research and development, and production [1]

Core Viewpoint - Haichuan Intelligent (300720) has shown a significant increase in stock price and market capitalization, alongside strategic financial management through government bond reverse repurchase agreements [1] Group 1: Stock Performance - As of January 16, 2026, Haichuan Intelligent closed at 34.69 yuan, up 7.93% from the previous trading day [1] - The stock opened at 32.5 yuan, reached a high of 35.04 yuan, and a low of 32.25 yuan, with a trading volume of 3.78 billion yuan and a turnover rate of 6.35% [1] Group 2: Financial Management - The company announced the use of idle self-owned funds for government bond reverse repurchase agreements, with a board meeting held on April 28, 2025, and a shareholder meeting on May 21, 2025, approving the use of up to 300 million yuan for cash management [1] - As of the announcement date, the principal and returns from previously matured investments have been fully recovered [1] - On January 15, 2026, the company subscribed to a 14-day product worth 101.32 million yuan with an annualized yield of 1.510%, maturing on January 28, 2026, with a total amount of 101.32 million yuan in reverse repurchase agreements yet to mature [1]

Core Viewpoint - Zhejiang Xinxing Technology Co., Ltd. (referred to as "Xinxing Technology") faced a delay in its IPO review on January 16, marking the first delayed IPO project for the three major exchanges in 2026 [1][2]. Group 1: Company Overview - Xinxing Technology specializes in the research, production, and sales of computer embroidery machines [1][2]. - The company’s IPO was accepted on June 26, 2025, and entered the inquiry stage on July 23 of the same year [1][2]. - Xinxing Technology aims to raise approximately 449 million yuan through this IPO [1][2]. Group 2: Regulatory Requirements - The listing committee requested the sponsoring institution and the reporting accountant to further investigate all sales customers with "cross-border foreign exchange payment capabilities," including agreements and execution regarding fund payments and business expenses [1][2]. - The committee also required Xinxing Technology to disclose details about borrowing from subsidiaries to implement fundraising projects and to ensure effective control over the use of raised funds to prevent interest transfer and protect the interests of the company and minority investors [1][2]. - Additionally, the committee inquired about the authenticity and sustainability of the company's operating performance and the implementation of fundraising projects through its controlling subsidiaries [1][2].

Group 1 - The company Tianqiao Crane (002523) reported that as of January 9, the number of its shareholders was 56,755 [1]

证券之星消息，截至2026年1月16日收盘，迈得医疗(688310)报收于16.15元，上涨1.57%，换手率 1.6%，成交量2.65万手，成交额4250.62万元。 1月16日的资金流向数据方面，主力资金净流入362.03万元，占总成交额8.52%，游资资金净流出398.27 万元，占总成交额9.37%，散户资金净流入36.24万元，占总成交额0.85%。 近5日资金流向一览见下表： 迈得医疗2025年三季报显示，前三季度公司主营收入2.25亿元，同比上升2.31%；归母净利润883.67万 元，同比上升15.82%；扣非净利润-127.85万元，同比下降526.58%；其中2025年第三季度，公司单季度 主营收入8364.3万元，同比上升54.38%；单季度归母净利润279.16万元，同比上升224.07%；单季度扣 非净利润123.64万元，同比上升118.23%；负债率29.86%，投资收益16.76万元，财务费用-52.36万元， 毛利率40.19%。迈得医疗（688310）主营业务：医用耗材智能装备的研发、生产、销售和服务,有效整 合医疗器械产品工艺、自动化、软件等方面的技术,形成独特的产品与服 ...